SinoMab BioScience Limited (HKG:3681)

Hong Kong · Delayed Price · Currency is HKD

1.950

-0.030 (-1.52%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	2.03M	1.37M	4.03M	26.66M	12.76M
Pharmaceuticals Growth	48.42%	-66.15%	-84.87%	108.91%	-
Total	2.03M	1.37M	4.03M	26.66M	12.76M
Total Growth	48.42%	-66.15%	-84.87%	108.91%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Mainland China	2.03M	1.37M	-	-	-
Mainland China Growth	48.42%	-	-	-	-
Hong Kong	-	-	-	25.91M	-
Total	2.03M	1.37M	-	25.91M	-
Total Growth	48.42%	-	-	-	-

Source: S&P Global Market Intelligence.